KLARIA PHARMA HOLDING AB has a total of 48 patent applications. It increased the IP activity by 70.0%. Its first patent ever was published in 2017. It filed its patents most often in WIPO (World Intellectual Property Organization), United Kingdom and Australia. Its main competitors in its focus markets pharmaceuticals and measurement are AIVIVA BIOPHARMA INC, GBS GLOBAL BIOPHARMA INC and PAK JAE WOO.
# | Country | Total Patents | |
---|---|---|---|
#1 | WIPO (World Intellectual Property Organization) | 7 | |
#2 | United Kingdom | 6 | |
#3 | Australia | 5 | |
#4 | Brazil | 5 | |
#5 | Canada | 5 | |
#6 | EPO (European Patent Office) | 5 | |
#7 | Israel | 4 | |
#8 | China | 3 | |
#9 | Republic of Korea | 3 | |
#10 | United States | 3 | |
#11 | Mexico | 2 |
# | Industry | |
---|---|---|
#1 | Pharmaceuticals | |
#2 | Measurement |
# | Technology | |
---|---|---|
#1 | Medical preparations | |
#2 | Therapeutic chemical compounds | |
#3 | Analysing materials |
# | Name | Total Patents |
---|---|---|
#1 | Boyer Scott | 26 |
#2 | Hübinette Fredrik | 19 |
#3 | Ingemarsson Leif | 19 |
#4 | Suchdev Susan | 13 |
#5 | Hubinette Fredrik | 11 |
#6 | Scott Boyer | 9 |
#7 | Leif Ingemarsson | 8 |
#8 | Fredrik Hübinette | 7 |
#9 | Susan Suchdev | 6 |
#10 | Mascher Erik | 6 |
Publication | Filing date | Title |
---|---|---|
GB201912505D0 | Pharmaceutical formulation | |
GB201911715D0 | Film formulation comprising carriers | |
AU2018386444A1 | Film formulation comprising vardenafil, method for its preparation, and use thereof | |
GB201815201D0 | Dissolution Device | |
GB201808462D0 | Pharmaceutical formulation | |
GB201807942D0 | Pharmaceutical formulation | |
US2020054550A1 | Pharmaceutical formulation | |
GB201709141D0 | Pharmaceutical formulation |